Skip to content

Soleus Capital Management, L.P.

Follow

13F filer, CIK 1802630, GREENWICH, CT

Soleus Capital Management, L.P. reported $2,813,021,888 across 97 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 52.96% of the portfolio.

Accepted , ingested 13F-HR 0001802630-26-000008

Period
2026-09-30
Reported value
$2.81B
Holdings
97
Top 10 weight
52.96%
New
27
Sold out
27

Part of the filer group Soleus Capital Management, L.P.

  • Guy Levy
  • Soleus Capital Group, LLC
  • Soleus GP, LLC
  • Soleus PE GP II, LLC
  • Soleus Private Equity Fund II, L.P.
  • Soleus Private Equity GP II, LLC
  • Soleus Capital Master Fund, L.P.
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PODDadded+677,500$88.4M
KRYSadded+200,446$66.7M
AXGNadded+1,023,964$42.9M
ZLABnew+1,543,000$40.6M
ERASadded+2,412,000$35.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INSPreduced-724,608-$50.3M
INDVreduced-1,054,000-$37.8M
GMEDexited-468,922-$37M
PRAXreduced-121,002-$35.2M
UNHreduced-79,340-$29.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001802630-26-000008, largest first. % of portfolio is the value over $2,813,021,888, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 358,379 shares; 2025Q1: 441,758 shares; 2025Q2: 922,958 shares; 2025Q3: 1,018,831 shares; 2025Q4: 941,059 shares; 2026Q1: 1,153,087 shares; 2026Q2: 939,254 shares; 2026Q3: 1,139,700 shares 1,139,700$379M13.47%+200,446Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 562,500 shares; 2026Q2: 1,049,000 shares; 2026Q3: 1,726,500 shares 1,726,500$225M8.01%+677,500Timeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,739,704 shares; 2025Q1: 5,521,414 shares; 2025Q2: 6,904,302 shares; 2025Q3: 9,644,872 shares; 2025Q4: 8,530,665 shares; 2026Q1: 10,492,391 shares; 2026Q2: 9,913,401 shares; 2026Q3: 9,425,776 shares 9,425,776$150M5.34%-487,625Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,681,242 shares; 2025Q1: 2,846,703 shares; 2025Q2: 2,243,935 shares; 2025Q3: 3,844,731 shares; 2025Q4: 3,139,312 shares; 2026Q1: 4,029,319 shares; 2026Q2: 2,927,895 shares; 2026Q3: 2,556,168 shares 2,556,168$143M5.07%-371,727Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 109,394 shares; 2025Q1: 155,394 shares; 2025Q2: 209,794 shares; 2025Q3: 150,000 shares; 2025Q4: 60,000 shares; 2026Q1: 187,187 shares; 2026Q2: 225,587 shares; 2026Q3: 259,000 shares 259,000$140M4.99%+33,413Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,565,087 shares; 2025Q1: 2,574,122 shares; 2025Q2: 3,011,818 shares; 2025Q3: 1,178,860 shares; 2025Q4: 1,808,258 shares; 2026Q1: 1,284,378 shares; 2026Q2: 1,704,318 shares; 2026Q3: 1,682,760 shares 1,682,760$134M4.76%-21,558Timeline
RIGLRIGEL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,130,679 shares; 2025Q1: 1,130,679 shares; 2025Q2: 658,145 shares; 2025Q3: 330,010 shares; 2025Q4: 300,034 shares; 2026Q1: 10,000 shares; 2026Q2: 1,843,504 shares; 2026Q3: 1,843,504 shares 1,843,504$88.8M3.16%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 39,000 shares; 2025Q2: 109,000 shares; 2025Q3: 728,188 shares; 2025Q4: 299,399 shares; 2026Q1: 576,299 shares; 2026Q2: 1,931,436 shares; 2026Q3: 1,206,828 shares 1,206,828$83.7M2.98%-724,608Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,162,162 shares; 2025Q1: 2,162,162 shares; 2025Q2: 2,162,162 shares; 2025Q3: 2,162,162 shares; 2025Q4: 2,162,162 shares; 2026Q1: not reported; 2026Q2: 2,700,000 shares; 2026Q3: 5,112,000 shares 5,112,000$74.9M2.66%+2,412,000Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,395,341 shares; 2025Q2: 3,820,158 shares; 2025Q3: 3,870,158 shares; 2025Q4: 2,534,565 shares; 2026Q1: 4,354,501 shares; 2026Q2: 4,393,714 shares; 2026Q3: 3,743,714 shares 3,743,714$71.1M2.53%-650,000Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 205,294 shares; 2025Q1: 224,684 shares; 2025Q2: 50,743 shares; 2025Q3: 340,243 shares; 2025Q4: 486,243 shares; 2026Q1: 820,243 shares; 2026Q2: 867,760 shares; 2026Q3: 975,500 shares 975,500$70.9M2.52%+107,740Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 80,696 shares; 2025Q1: not reported; 2025Q2: 50,953 shares; 2025Q3: 497,953 shares; 2025Q4: 764,000 shares; 2026Q1: 2,549,079 shares; 2026Q2: 1,459,152 shares; 2026Q3: 1,554,059 shares 1,554,059$62.4M2.22%+94,907Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,400,000 shares; 2025Q2: 16,140,000 shares; 2025Q3: 17,290,000 shares; 2025Q4: 23,290,000 shares; 2026Q1: 41,508,659 shares; 2026Q2: 42,808,659 shares; 2026Q3: 46,768,659 shares 46,768,659$57.5M2.04%+3,960,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,465,070 shares; 2026Q3: 1,684,512 shares 1,684,512$54.4M1.93%+219,442Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 28,940 shares; 2025Q2: 42,876 shares; 2025Q3: 69,426 shares; 2025Q4: 31,726 shares; 2026Q1: 3,500 shares; 2026Q2: 19,955 shares; 2026Q3: 49,350 shares 49,350$47.3M1.68%+29,395Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,955,943 shares; 2025Q1: 1,446,117 shares; 2025Q2: 1,459,395 shares; 2025Q3: 1,726,553 shares; 2025Q4: 1,206,855 shares; 2026Q1: 679,170 shares; 2026Q2: 57,036 shares; 2026Q3: 1,081,000 shares 1,081,000$45.3M1.61%+1,023,964Timeline
NPCENEUROPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,433,168 shares; 2025Q1: 2,608,168 shares; 2025Q2: 2,312,957 shares; 2025Q3: 2,957,957 shares; 2025Q4: 2,703,208 shares; 2026Q1: 2,932,207 shares; 2026Q2: 2,911,122 shares; 2026Q3: 3,218,000 shares 3,218,000$44.3M1.57%+306,878Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 697,158 shares; 2025Q1: 1,079,158 shares; 2025Q2: 2,119,000 shares; 2025Q3: 1,450,000 shares; 2025Q4: 1,070,000 shares; 2026Q1: 2,245,360 shares; 2026Q2: 822,428 shares; 2026Q3: 5,090,000 shares 5,090,000$40.7M1.45%+4,267,572Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,543,000 shares 1,543,000$40.6M1.44%newTimeline
PGNYPROGYNY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,067,000 shares; 2026Q2: 1,602,000 shares; 2026Q3: 1,582,000 shares 1,582,000$39.9M1.42%-20,000Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 700,000 shares; 2025Q3: 25,000 shares; 2025Q4: 900,000 shares; 2026Q1: 1,620,000 shares; 2026Q2: 1,179,618 shares; 2026Q3: 2,727,727 shares 2,727,727$39.1M1.39%+1,548,109Timeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 1,710,658 shares 1,710,658$36.1M1.28%+710,658Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,309,254 shares; 2025Q1: 7,309,254 shares; 2025Q2: 7,309,254 shares; 2025Q3: 7,309,254 shares; 2025Q4: 7,309,254 shares; 2026Q1: 7,309,254 shares; 2026Q2: 7,309,254 shares; 2026Q3: 7,309,254 shares 7,309,254$32.7M1.16%0Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 419,000 shares; 2026Q3: 1,019,000 shares 1,019,000$29M1.03%+600,000Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 19,644 shares; 2025Q4: 60,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 286,966 shares 286,966$27.2M0.97%newTimeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 630,000 shares; 2026Q3: 2,385,700 shares 2,385,700$26.1M0.93%+1,755,700Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,325,000 shares; 2025Q1: 6,325,000 shares; 2025Q2: 6,325,000 shares; 2025Q3: 6,325,000 shares; 2025Q4: 10,875,000 shares; 2026Q1: 10,875,000 shares; 2026Q2: 10,875,000 shares; 2026Q3: 11,225,000 shares 11,225,000$23.1M0.82%+350,000Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 711,983 shares; 2026Q1: 451,983 shares; 2026Q2: 1,168,738 shares; 2026Q3: 862,000 shares 862,000$22.3M0.79%-306,738Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,205,000 shares; 2026Q3: 1,085,550 shares 1,085,550$21.6M0.77%-119,450Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,102,833 shares; 2025Q1: 2,422,833 shares; 2025Q2: 2,422,833 shares; 2025Q3: 2,422,833 shares; 2025Q4: 1,219,394 shares; 2026Q1: 938,163 shares; 2026Q2: 1,465,163 shares; 2026Q3: 892,163 shares 892,163$21.2M0.75%-573,000Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 131,000 shares; 2026Q2: not reported; 2026Q3: 210,000 shares 210,000$21M0.75%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 405,523 shares; 2026Q3: 1,272,355 shares 1,272,355$20.4M0.72%+866,832Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,063,687 shares; 2026Q3: 14,996,154 shares 14,996,154$20.2M0.72%+1,932,467Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,322,364 shares; 2026Q1: 1,970,864 shares; 2026Q2: 1,029,252 shares; 2026Q3: 497,706 shares 497,706$20.2M0.72%-531,546Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 730,000 shares; 2025Q3: 300,000 shares; 2025Q4: 10,000 shares; 2026Q1: 450,000 shares; 2026Q2: 709,000 shares; 2026Q3: 802,297 shares 802,297$20M0.71%+93,297Timeline
BDSXBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 416,599 shares; 2026Q2: 585,958 shares; 2026Q3: 667,835 shares 667,835$19.9M0.71%+81,877Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 814,652 shares; 2025Q1: 814,652 shares; 2025Q2: 732,968 shares; 2025Q3: 647,052 shares; 2025Q4: 702,052 shares; 2026Q1: 702,052 shares; 2026Q2: 730,907 shares; 2026Q3: 604,000 shares 604,000$19.2M0.68%-126,907Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 320,272 shares; 2025Q1: 274,272 shares; 2025Q2: 72,772 shares; 2025Q3: 2,550 shares; 2025Q4: 48,500 shares; 2026Q1: 10,250 shares; 2026Q2: 90,250 shares; 2026Q3: 147,000 shares 147,000$16.8M0.6%+56,750Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 243,540 shares; 2025Q1: 1,139,740 shares; 2025Q2: 966,740 shares; 2025Q3: 859,166 shares; 2025Q4: 362,966 shares; 2026Q1: 330,517 shares; 2026Q2: 177,517 shares; 2026Q3: 56,515 shares 56,515$16.5M0.59%-121,002Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 796,744 shares; 2025Q3: 796,744 shares; 2025Q4: 796,744 shares; 2026Q1: 796,744 shares; 2026Q2: 1,550,690 shares; 2026Q3: 1,170,928 shares 1,170,928$16.5M0.58%-379,762Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 469,500 shares; 2025Q2: 254,689 shares; 2025Q3: 150,000 shares; 2025Q4: 587,000 shares; 2026Q1: 521,353 shares; 2026Q2: 246,353 shares; 2026Q3: 218,958 shares 218,958$16.3M0.58%-27,395Timeline
CNMDCONMED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 347,333 shares 347,333$16.1M0.57%newTimeline
ETONETON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 285,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: 166,381 shares; 2026Q2: not reported; 2026Q3: 308,101 shares 308,101$15.9M0.56%newTimeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 128,000 shares; 2025Q4: 525,447 shares; 2026Q1: 615,447 shares; 2026Q2: 732,144 shares; 2026Q3: 710,198 shares 710,198$15.8M0.56%-21,946Timeline
ORGOORGANOGENESIS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,484,876 shares; 2025Q1: 12,478,351 shares; 2025Q2: 12,343,351 shares; 2025Q3: 12,131,699 shares; 2025Q4: 9,985,951 shares; 2026Q1: 10,085,951 shares; 2026Q2: 10,140,951 shares; 2026Q3: 11,300,951 shares 11,300,951$15.5M0.55%+1,160,000Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 108,500 shares 108,500$15.2M0.54%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 275,000 shares; 2025Q4: 408,900 shares; 2026Q1: 178,897 shares; 2026Q2: 515,279 shares; 2026Q3: 258,897 shares 258,897$15.2M0.54%-256,382Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 183,300 shares; 2025Q1: 72,300 shares; 2025Q2: 76,493 shares; 2025Q3: not reported; 2025Q4: 910,000 shares; 2026Q1: 1,449,915 shares; 2026Q2: 450,889 shares; 2026Q3: 329,987 shares 329,987$13.4M0.48%-120,902Timeline
AMRXAMNEAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 658,000 shares 658,000$13.3M0.47%newTimeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,378,378 shares; 2026Q3: 3,378,378 shares 3,378,378$13.2M0.47%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 675,409 shares; 2025Q1: 751,353 shares; 2025Q2: 75,456 shares; 2025Q3: 18,260 shares; 2025Q4: 383,368 shares; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares; 2026Q3: 330,000 shares 330,000$12.9M0.46%+55,000Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,492,000 shares; 2025Q1: 816,610 shares; 2025Q2: 1,092,110 shares; 2025Q3: 2,012,110 shares; 2025Q4: 2,247,110 shares; 2026Q1: 1,726,908 shares; 2026Q2: 1,628,039 shares; 2026Q3: 615,990 shares 615,990$11.6M0.41%-1,012,049Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 226,218 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 275,000 shares 275,000$11.3M0.4%newTimeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,978,942 shares; 2025Q1: 6,978,942 shares; 2025Q2: 6,978,942 shares; 2025Q3: 7,053,942 shares; 2025Q4: 3,803,942 shares; 2026Q1: 3,803,942 shares; 2026Q2: 3,377,981 shares; 2026Q3: 3,357,981 shares 3,357,981$11.2M0.4%-20,000Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,000 shares; 2026Q2: 1,003,000 shares; 2026Q3: 600,358 shares 600,358$10.9M0.39%-402,642Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 125,000 shares; 2026Q1: 10,000 shares; 2026Q2: not reported; 2026Q3: 445,025 shares 445,025$9.73M0.35%newTimeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 416,993 shares 416,993$9.39M0.33%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,185,000 shares; 2025Q3: 679,000 shares; 2025Q4: 150,000 shares; 2026Q1: 727,000 shares; 2026Q2: 829,810 shares; 2026Q3: 230,274 shares 230,274$9.36M0.33%-599,536Timeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 354,401 shares; 2025Q3: 1,866,234 shares; 2025Q4: 1,861,802 shares; 2026Q1: 1,226,629 shares; 2026Q2: 104,629 shares; 2026Q3: 47,532 shares 47,532$9.19M0.33%-57,097Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 52,500 shares 52,500$8.48M0.3%newTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,560,000 shares; 2025Q1: 7,785,000 shares; 2025Q2: 3,261,707 shares; 2025Q3: 976,707 shares; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 150,000 shares; 2026Q3: 551,977 shares 551,977$8.18M0.29%+401,977Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 78,800 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 292,000 shares; 2026Q2: 267,000 shares; 2026Q3: 205,000 shares 205,000$7.62M0.27%-62,000Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 201,084 shares; 2025Q1: 84,784 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,249 shares 36,249$7.44M0.26%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,001,400 shares; 2025Q1: 1,079,304 shares; 2025Q2: 902,304 shares; 2025Q3: 890,304 shares; 2025Q4: 1,320,000 shares; 2026Q1: 650,572 shares; 2026Q2: 375,572 shares; 2026Q3: 121,120 shares 121,120$7.27M0.26%-254,452Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 646,390 shares; 2026Q1: not reported; 2026Q2: 761,737 shares; 2026Q3: 699,149 shares 699,149$6.62M0.24%-62,588Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,708,727 shares; 2026Q1: 7,708,727 shares; 2026Q2: 7,708,727 shares; 2026Q3: 7,524,958 shares 7,524,958$6.55M0.23%-183,769Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,038,323 shares; 2026Q1: 2,788,323 shares; 2026Q2: 2,788,323 shares; 2026Q3: 3,088,323 shares 3,088,323$5.9M0.21%+300,000Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 441,978 shares; 2026Q1: 441,978 shares; 2026Q2: 1,654,978 shares; 2026Q3: 383,594 shares 383,594$5.88M0.21%-1,271,384Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 252,917 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 141,137 shares 141,137$5.01M0.18%newTimeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 140,500 shares 140,500$4.98M0.18%newTimeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,552 shares 25,552$4.2M0.15%newTimeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,000 shares 225,000$2.81M0.1%newTimeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$2.81M0.1%newTimeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 414,359 shares; 2026Q2: 314,359 shares; 2026Q3: 330,102 shares 330,102$2.81M0.1%+15,743Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 368,123 shares 368,123$2.66M0.09%+218,123Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,050,000 shares; 2026Q2: 900,000 shares; 2026Q3: 672,039 shares 672,039$2.13M0.08%-227,961Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,963,141 shares; 2026Q2: 7,063,141 shares; 2026Q3: 7,063,141 shares 7,063,141$2.12M0.08%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 950,000 shares; 2026Q3: 706,280 shares 706,280$1.96M0.07%-243,720Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 496,039 shares; 2025Q2: 200,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 783,000 shares; 2026Q2: 575,000 shares; 2026Q3: 100,000 shares 100,000$1.63M0.06%-475,000Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$1.27M0.05%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,100 shares 300,100$1.17M0.04%newTimeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 10,753,700 shares; 2026Q2: 2,500,000 shares; 2026Q3: 450,000 shares 450,000$1.07M0.04%-2,050,000Timeline
QGENQIAGEN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$875K0.03%newTimeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000$750K0.03%newTimeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,378,128 shares; 2025Q1: 945,376 shares; 2025Q2: 1,886,207 shares; 2025Q3: 1,470,934 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,045,708 shares; 2026Q2: 1,045,708 shares; 2026Q3: 1,045,708 shares 1,045,708$698K0.02%0Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,000 shares 90,000$451K0.02%newTimeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,274,000 shares; 2026Q2: 1,064,000 shares; 2026Q3: 10,000 shares 10,000$358K0.01%-1,054,000Timeline
PCSAPROCESSA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 160,943 shares 160,943$264K0.01%newTimeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,000 shares; 2025Q4: 40,354 shares; 2026Q1: not reported; 2026Q2: 50,524 shares; 2026Q3: 1,524 shares 1,524$259K0.01%-49,000Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,500 shares 2,500$246K0.01%newTimeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 86,250 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares; 2026Q3: 660 shares 660$242K0.01%-79,340Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,002,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 20,971 shares 20,971$234K0.01%-979,029Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 547,082 shares; 2025Q1: not reported; 2025Q2: 174,000 shares; 2025Q3: 375,000 shares; 2025Q4: 75,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$211K0.01%newTimeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$171K0.01%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 90,000 shares; 2026Q3: 90,000 shares 90,000$146K0.01%0Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$98K<0.01%newTimeline
SOPHSOPHIA GENETICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,850,000 shares; 2026Q2: 1,565,000 shares; 2026Q3: 10,000 shares 10,000$83.8K<0.01%-1,555,000Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GMEDGLOBUS MED INC468,922$37Mshares
SUPNSUPERNUS PHARMACEUTICALS520,000$24.2Mshares
LIVNLIVANOVA PLC254,957$21Mshares
SYRESPYRE THERAPEUTICS INC147,000$13.1Mshares
ALNYALNYLAM PHARMACEUTICALS INC33,050$9.95Mshares
IMVTIMMUNOVANT INC252,000$9.71Mshares
NKTRNEKTAR THERAPEUTICS128,362$8.96Mshares
MIRMMIRUM PHARMACEUTICALS INC75,000$8.78Mshares
AORTARTIVION INC388,000$8.72Mshares
ELVNENLIVEN THERAPEUTICS INC165,677$8.41Mshares
SIONSIONNA THERAPEUTICS INC177,687$7.82Mshares
IMUXIMMUNIC INC450,000$6.92Mshares
MRKMERCK & CO INC50,000$6.42Mshares
RLMDRELMADA THERAPEUTICS INC842,106$5.83Mshares
GPCRSTRUCTURE THERAPEUTICS INC107,000$5.74Mshares
KPTIKARYOPHARM THERAPEUTICS INC440,000$4.3Mshares
TECXTECTONIC THERAPEUTIC INC101,684$3.5Mshares
AVBPARRIVENT BIOPHARMA INC50,000$1.74Mshares
CORTCORCEPT THERAPEUTICS INC19,653$1.71Mshares
VCYTVERACYTE INC25,000$1.47Mshares
CGEMCULLINAN THERAPEUTICS INC50,000$910Kshares
WGSGENEDX HOLDINGS CORP10,000$686Kshares
LRMRLARIMAR THERAPEUTICS INC188,102$574Kshares
CGONCG ONCOLOGY INC5,000$355Kshares
QNRXQUOIN PHARMACEUTICALS LTD72,730$352Kshares
NTRANATERA INC1,000$271Kshares
NEONEOGENOMICS INC10,000$146Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001802630-26-000008 base2026-11-16